The US Food and Drug Administration (FDA) is planning to regulate the use of the cannabis compound CBD in food and supplements after weighing the evidence on the compound's safety.
The FDA will decide whether regulating legal cannabis will require new agency rules or new legislation from Congress.
Cannabis products, excluding Epidiolex, are illegal at the federal level in the US, although some states allow their use.
According to Patrick Cournoyer, who heads the FDA office developing the agency's cannabis strategy, the FDA will ascertain if CBD can be safely eaten every day for a long period or during pregnancy amid concerns about future fertility.
.


South Korea Factory Activity Returns to Growth in December on Export Rebound
Brazil Supreme Court Orders Asset Freeze of Nelson Tanure Amid Banco Master Investigation
U.S. and Rwanda Sign $228 Million Health Partnership to Boost Self-Reliance
Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market
Sanofi’s Efdoralprin Alfa Gains EMA Orphan Status for Rare Lung Disease
Alibaba-Backed Moonshot AI Unveils Kimi K2.5 to Challenge China’s AI Rivals
Meta Faces Lawsuit Over Alleged Approval of AI Chatbots Allowing Sexual Interactions With Minors
South Korean Won Slides Despite Government Efforts to Stabilize Currency Markets
Ford and GM Near Financing Deal to Support First Brands Group During Bankruptcy
Gold Prices Rebound in Europe as Geopolitical Tensions and Fed Outlook Support Bullion
The Maire - EuroChem Case: Three Lessons for Global Business
DOJ Urges Judge to Block Lawmakers’ Bid for Special Master in Jeffrey Epstein Records Case
California Attorney General Orders xAI to Halt Illegal Grok Deepfake Imagery
California Sues Trump Administration Over Federal Authority on Sable Offshore Pipelines
Forex Markets Hold Steady as Traders Await Fed Minutes Amid Thin Year-End Volumes 



